Chief Executive Officer
Michael Yurkowsky brings more than 25 years of experience in financial services to H-CYTE. In addition to serving as the Chief Executive Officer of H-CYTE, Yurkowsky currently serves as President and Chairman of Deverra Therapeutics, a clinical stage biotech developing allogeneic cell therapies.
Yurkowsky spent his early career working as a broker with several national broker-dealers and as a licensed investment banker. He went on to start and manage his own hedge fund, specializing in debt arbitrage. In 2012, he opened his own family office, YP Holdings LLC, which has invested in more than 50 private companies and participated in more than 100 public company financing transactions.
Throughout his career, Mr. Yurkowsky has served on multiple public and private boards and has been involved in several M&A transactions.